ÂÜÀòÂÒÂ×

For over 15 years, Mary has championed manufacturing quality and innovation for a wide variety of challenging biologic and drug development programs, including novel LBPs, complex combination products, and biologics manufactured under high biocontainment. Mary is a trained microbiologist, whose extensive experience in Quality and CMC Regulatory leadership on both the sponsor and contract manufacturing sides of development make her uniquely qualified to lead Siolta’s internal and outsourced clinical manufacturing. She has developed and managed quality systems for a variety of small companies and has supported CMC strategy and regulations for diverse programs, bringing key industry experience to the Siolta team.